These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15340733)

  • 21. Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes.
    Tushuizen ME; Diamant M; Heine RJ
    Postgrad Med J; 2005 Jan; 81(951):1-6. PubMed ID: 15640422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention Program.
    Kirkman MS; Shankar RR; Shankar S; Shen C; Brizendine E; Baron A; McGill J
    Diabetes Care; 2006 Sep; 29(9):2095-101. PubMed ID: 16936159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies.
    Levitan EB; Song Y; Ford ES; Liu S
    Arch Intern Med; 2004 Oct; 164(19):2147-55. PubMed ID: 15505129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From hyperglycemia to the risk of cardiovascular disease.
    Leiter LA
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-challenge hyperglycaemia rather than fasting hyperglycaemia is an independent risk factor of cardiovascular disease events.
    Gao W; Qiao Q; Tuomilehto J
    Clin Lab; 2004; 50(9-10):609-15. PubMed ID: 15481637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose control in the intensive care unit.
    Fahy BG; Sheehy AM; Coursin DB
    Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Epidemiology of macroangiopathy in diabetes, including international comparisons].
    Nishimura R
    Nihon Rinsho; 2006 Nov; 64(11):2012-8. PubMed ID: 17087291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cardiovascular effects of oral hypoglycemie drugs].
    Herrmann BL; Erbel R; Janssen OE; Mann K
    Herz; 2004 Aug; 29(5):510-8. PubMed ID: 15340737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients.
    Scognamiglio R; Negut C; De Kreutzenberg SV; Tiengo A; Avogaro A
    Circulation; 2005 Jul; 112(2):179-84. PubMed ID: 15998667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetes.
    Triggle CR
    Timely Top Med Cardiovasc Dis; 2008 Feb; 12():E3. PubMed ID: 18392213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperglycemia in the hospital setting: the case for improved control among non-diabetics.
    Conner TM; Flesner-Gurley KR; Barner JC
    Ann Pharmacother; 2005 Mar; 39(3):492-501. PubMed ID: 15701779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the efficacy, safety and tolerability of miglitol in adult Indian patients with uncomplicated type 2 diabetes mellitus.
    Singh KP; Periyandavar I; Rajadhyaksha GC; Jayaram S; Mishra AB; Kinagi S; Sharma A; Baliga VP
    J Indian Med Assoc; 2007 Jun; 105(6):344, 346, 350. PubMed ID: 18232183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing cardiovascular outcomes in diabetes mellitus.
    Sobel BE
    Am J Med; 2007 Sep; 120(9 Suppl 2):S3-11. PubMed ID: 17826044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Postprandial hyperglycemia as a risk factor in the development of endothelial dysfunction--how to prevent?].
    Ljubić S; Boras J; Vidjak V
    Lijec Vjesn; 2008; 130(1-2):21-5. PubMed ID: 18589639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early detection and integrated management of dysglycemia in cardiovascular disease: a key factor for decreasing the likelihood of future events.
    Anselmino M; Mellbin L; Wallander M; Rydén L
    Rev Cardiovasc Med; 2008; 9(1):29-38. PubMed ID: 18418307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The rationale for paired pre- and postprandial self-monitoring of blood glucose: the role of glycemic variability in micro- and macrovascular risk.
    Gerich JE; Odawara M; Terauchi Y
    Curr Med Res Opin; 2007 Aug; 23(8):1791-8. PubMed ID: 17610805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The clinical significance of early intervention for impaired glucose tolerance].
    Kawanami D; Utsunomiya K
    Nihon Rinsho; 2010 May; 68(5):797-802. PubMed ID: 20446571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.